Skip to main content

Table 1 Clinicopathological characteristics of patients

From: Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma

ID

Age

Gender

ENSAT 2008 Stage

Metastasis

Diameter

Hormonal profile

Recurrence

C1

58

F

III

N

13 cm

Non-functional

Y

C2

32

F

III

N

12 cm

Androgen-producing

N

C3

62

F

III

Y

14 cm

Cortisol-producing

Y

C4

48

M

III

N

9 cm

Non-functional

N

C5

48

F

III

N

13 cm

Cortisol-producing

Y

C6

55

F

IV

Y

5.5 cm

Cortisol-producing

Y

C7

60

F

IV

Y

7.8 cm

Cortisol-producing

Y

  1. Diverse clinical and pathological characteristics of adrenocortical cancer (n = 7) patients selected for the study, is shown. ENSAT 2008 Staging: European Network for the Study of Endocrine Tumors; Y = Yes, N = No, F = Female, M = Male.